ID   FMR1_RAT                Reviewed;         593 AA.
AC   Q80WE1; P70568;
DT   01-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-2008, sequence version 2.
DT   02-OCT-2024, entry version 149.
DE   RecName: Full=Fragile X messenger ribonucleoprotein 1 {ECO:0000305};
DE   AltName: Full=Fragile X messenger ribonucleoprotein {ECO:0000305};
DE            Short=FMRP {ECO:0000303|Ref.1};
GN   Name=Fmr1 {ECO:0000312|RGD:2623};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   STRAIN=Sprague-Dawley;
RA   Rackham O., Brown C.M.;
RT   "Messenger RNA encoding FMRP isoform 18 from the rat hippocampus.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 42-587 (ISOFORM 1).
RC   STRAIN=Wistar; TISSUE=Brain;
RA   Huang T., Ji H., Sittler A., Shen Y., Mandel J., Wu G.;
RT   "Cloning of rat FMR1 gene.";
RL   Submitted (JUN-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   SUBCELLULAR LOCATION, AND ASSOCIATION WITH POLYRIBOSOME.
RX   PubMed=9030614; DOI=10.1523/jneurosci.17-05-01539.1997;
RA   Feng Y., Gutekunst C.A., Eberhart D.E., Yi H., Warren S.T., Hersch S.M.;
RT   "Fragile X mental retardation protein: nucleocytoplasmic shuttling and
RT   association with somatodendritic ribosomes.";
RL   J. Neurosci. 17:1539-1547(1997).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, ASSOCIATION WITH POLYRIBOSOME, AND
RP   INDUCTION.
RX   PubMed=9144248; DOI=10.1073/pnas.94.10.5395;
RA   Weiler I.J., Irwin S.A., Klintsova A.Y., Spencer C.M., Brazelton A.D.,
RA   Miyashiro K., Comery T.A., Patel B., Eberwine J., Greenough W.T.;
RT   "Fragile X mental retardation protein is translated near synapses in
RT   response to neurotransmitter activation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:5395-5400(1997).
RN   [5]
RP   SUBCELLULAR LOCATION, ASSOCIATION WITH POLYRIBOSOME, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=14613971; DOI=10.1093/hmg/ddh009;
RA   Wang H., Ku L., Osterhout D.J., Li W., Ahmadian A., Liang Z., Feng Y.;
RT   "Developmentally-programmed FMRP expression in oligodendrocytes: a
RT   potential role of FMRP in regulating translation in oligodendroglia
RT   progenitors.";
RL   Hum. Mol. Genet. 13:79-89(2004).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15028757; DOI=10.1523/jneurosci.0099-04.2004;
RA   Antar L.N., Afroz R., Dictenberg J.B., Carroll R.C., Bassell G.J.;
RT   "Metabotropic glutamate receptor activation regulates fragile x mental
RT   retardation protein and FMR1 mRNA localization differentially in dendrites
RT   and at synapses.";
RL   J. Neurosci. 24:2648-2655(2004).
RN   [7]
RP   SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=15564573; DOI=10.1523/jneurosci.2185-04.2004;
RA   Gabel L.A., Won S., Kawai H., McKinney M., Tartakoff A.M., Fallon J.R.;
RT   "Visual experience regulates transient expression and dendritic
RT   localization of fragile X mental retardation protein.";
RL   J. Neurosci. 24:10579-10583(2004).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16098134; DOI=10.1111/j.1601-183x.2005.00128.x;
RA   Antar L.N., Dictenberg J.B., Plociniak M., Afroz R., Bassell G.J.;
RT   "Localization of FMRP-associated mRNA granules and requirement of
RT   microtubules for activity-dependent trafficking in hippocampal neurons.";
RL   Genes Brain Behav. 4:350-359(2005).
RN   [9]
RP   SUBCELLULAR LOCATION, ASSOCIATION WITH POLYRIBOSOME, AND ASSOCIATION WITH
RP   MRNP.
RX   PubMed=16571602; DOI=10.1093/hmg/ddl074;
RA   Davidovic L., Bechara E., Gravel M., Jaglin X.H., Tremblay S., Sik A.,
RA   Bardoni B., Khandjian E.W.;
RT   "The nuclear microspherule protein 58 is a novel RNA-binding protein that
RT   interacts with fragile X mental retardation protein in polyribosomal mRNPs
RT   from neurons.";
RL   Hum. Mol. Genet. 15:1525-1538(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-336; SER-337; SER-347;
RP   SER-349 AND SER-350, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [11]
RP   INTERACTION WITH KCNT1.
RX   PubMed=20512134; DOI=10.1038/nn.2563;
RA   Brown M.R., Kronengold J., Gazula V.R., Chen Y., Strumbos J.G.,
RA   Sigworth F.J., Navaratnam D., Kaczmarek L.K.;
RT   "Fragile X mental retardation protein controls gating of the sodium-
RT   activated potassium channel Slack.";
RL   Nat. Neurosci. 13:819-821(2010).
RN   [12]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=23891804; DOI=10.1016/j.mcn.2013.07.009;
RA   Giampetruzzi A., Carson J.H., Barbarese E.;
RT   "FMRP and myelin protein expression in oligodendrocytes.";
RL   Mol. Cell. Neurosci. 56:333-341(2013).
RN   [13]
RP   FUNCTION, INTERACTION WITH CACNA1B, AND SUBCELLULAR LOCATION.
RX   PubMed=24709664; DOI=10.1038/ncomms4628;
RA   Ferron L., Nieto-Rostro M., Cassidy J.S., Dolphin A.C.;
RT   "Fragile X mental retardation protein controls synaptic vesicle exocytosis
RT   by modulating N-type calcium channel density.";
RL   Nat. Commun. 5:3628-3628(2014).
CC   -!- FUNCTION: Multifunctional polyribosome-associated RNA-binding protein
CC       that plays a central role in neuronal development and synaptic
CC       plasticity through the regulation of alternative mRNA splicing, mRNA
CC       stability, mRNA dendritic transport and postsynaptic local protein
CC       synthesis of target mRNAs (PubMed:9144248). Acts as an mRNA regulator
CC       by mediating formation of some phase-separated membraneless
CC       compartment: undergoes liquid-liquid phase separation upon binding to
CC       target mRNAs, leading to assemble mRNAs into cytoplasmic
CC       ribonucleoprotein granules that concentrate mRNAs with associated
CC       regulatory factors (By similarity). Plays a role in the alternative
CC       splicing of its own mRNA (By similarity). Stabilizes the scaffolding
CC       postsynaptic density protein DLG4/PSD-95 and the myelin basic protein
CC       (MBP) mRNAs in hippocampal neurons and glial cells, respectively; this
CC       stabilization is further increased in response to metabotropic
CC       glutamate receptor (mGluR) stimulation (By similarity). Plays a role in
CC       selective delivery of a subset of dendritic mRNAs to synaptic sites in
CC       response to mGluR activation in a kinesin-dependent manner (By
CC       similarity). Undergoes liquid-liquid phase separation following
CC       phosphorylation and interaction with CAPRIN1, promoting formation of
CC       cytoplasmic ribonucleoprotein granules that concentrate mRNAs with
CC       factors that inhibit translation and mediate deadenylation of target
CC       mRNAs. Acts as a repressor of mRNA translation in synaptic regions by
CC       mediating formation of neuronal ribonucleoprotein granules and
CC       promoting recruitmtent of EIF4EBP2. Plays a role as a repressor of mRNA
CC       translation during the transport of dendritic mRNAs to postsynaptic
CC       dendritic spines (PubMed:9144248). Component of the CYFIP1-EIF4E-FMR1
CC       complex which blocks cap-dependent mRNA translation initiation (By
CC       similarity). Represses mRNA translation by stalling ribosomal
CC       translocation during elongation (By similarity). Reports are
CC       contradictory with regards to its ability to mediate translation
CC       inhibition of MBP mRNA in oligodendrocytes. Also involved in the
CC       recruitment of the RNA helicase MOV10 to a subset of mRNAs and hence
CC       regulates microRNA (miRNA)-mediated translational repression by AGO2.
CC       Facilitates the assembly of miRNAs on specific target mRNAs. Also plays
CC       a role as an activator of mRNA translation of a subset of dendritic
CC       mRNAs at synapses (By similarity). In response to mGluR stimulation,
CC       FMR1-target mRNAs are rapidly derepressed, allowing for local
CC       translation at synapses (By similarity). Binds to a large subset of
CC       dendritic mRNAs that encode a myriad of proteins involved in pre- and
CC       postsynaptic functions. Binds to 5'-ACU[GU]-3' and/or 5'-[AU]GGA-3' RNA
CC       consensus sequences within mRNA targets, mainly at coding sequence
CC       (CDS) and 3'-untranslated region (UTR) and less frequently at 5'-UTR.
CC       Binds to intramolecular G-quadruplex structures in the 5'- or 3'-UTRs
CC       of mRNA targets. Binds to G-quadruplex structures in the 3'-UTR of its
CC       own mRNA. Binds also to RNA ligands harboring a kissing complex (kc)
CC       structure; this binding may mediate the association of FMR1 with
CC       polyribosomes. Binds mRNAs containing U-rich target sequences. Binds to
CC       a triple stem-loop RNA structure, called Sod1 stem loop interacting
CC       with FMRP (SoSLIP), in the 5'-UTR region of superoxide dismutase SOD1
CC       mRNA (By similarity). Binds to the dendritic, small non-coding brain
CC       cytoplasmic RNA 1 (BC1); which may increase the association of the
CC       CYFIP1-EIF4E-FMR1 complex to FMR1 target mRNAs at synapses (By
CC       similarity). Plays a role in mRNA nuclear export. Specifically
CC       recognizes and binds a subset of N6-methyladenosine (m6A)-containing
CC       mRNAs, promoting their nuclear export in a XPO1/CRM1-dependent manner
CC       (By similarity). Together with export factor NXF2, is involved in the
CC       regulation of the NXF1 mRNA stability in neurons (By similarity).
CC       Associates with export factor NXF1 mRNA-containing ribonucleoprotein
CC       particles (mRNPs) in a NXF2-dependent manner (By similarity). Binds to
CC       a subset of miRNAs in the brain. May associate with nascent transcripts
CC       in a nuclear protein NXF1-dependent manner. In vitro, binds to RNA
CC       homomer; preferentially on poly(G) and to a lesser extent on poly(U),
CC       but not on poly(A) or poly(C). Moreover, plays a role in the modulation
CC       of the sodium-activated potassium channel KCNT1 gating activity (By
CC       similarity). Negatively regulates the voltage-dependent calcium channel
CC       current density in soma and presynaptic terminals of dorsal root
CC       ganglion (DRG) neurons, and hence regulates synaptic vesicle exocytosis
CC       (PubMed:24709664). Modulates the voltage-dependent calcium channel
CC       CACNA1B expression at the plasma membrane by targeting the channels for
CC       proteasomal degradation (By similarity). Plays a role in regulation of
CC       MAP1B-dependent microtubule dynamics during neuronal development (By
CC       similarity). Has been shown to play a translation-independent role in
CC       the modulation of presynaptic action potential (AP) duration and
CC       neurotransmitter release via large-conductance calcium-activated
CC       potassium (BK) channels in hippocampal and cortical excitatory neurons.
CC       Finally, FMR1 may be involved in the control of DNA damage response
CC       (DDR) mechanisms through the regulation of ATR-dependent signaling
CC       pathways such as histone H2AX/H2A.x and BRCA1 phosphorylations (By
CC       similarity). {ECO:0000250|UniProtKB:P35922,
CC       ECO:0000250|UniProtKB:Q06787, ECO:0000269|PubMed:24709664,
CC       ECO:0000269|PubMed:9144248}.
CC   -!- SUBUNIT: Homodimer (By similarity). Forms heterodimer with FXR1;
CC       heterodimerization occurs in a methylation-dependent manner (By
CC       similarity). Forms heterodimer with FXR2 (By similarity). Homooligomer
CC       (By similarity). Component of the CYFIP1-EIF4E-FMR1 complex at least
CC       composed of CYFIP, EIF4E and FMR1; this mRNA cap binding complex
CC       formation increases in presence of the brain cytoplasmic RNA BC1 and is
CC       dynamically regulated in an activity-dependent manner to repress and
CC       then possibly release dendritic mRNAs for translation in response to
CC       mGluR stimulation (By similarity). Associates with the SMN core complex
CC       that contains SMN, GEMIN2/SIP1, DDX20/GEMIN3, GEMIN4, GEMIN5, GEMIN6,
CC       GEMIN7, GEMIN8 and STRAP/UNRIP (By similarity). Part of a
CC       ribonucleoprotein complex with AGO2/EIF2C2 and miRNAs (By similarity).
CC       Interacts with AGO2/EIF2C2 (By similarity). Interacts (via C-terminus)
CC       with CACNA1B; this interaction induces a decrease in the number of
CC       presynaptic functional CACNA1B channels at the cell surface
CC       (PubMed:24709664). Interacts with CYFIP1; this interaction recruits
CC       CYFIP1 to capped mRNA. Interacts with CYFIP2 (By similarity). Interacts
CC       with EIF5; this interaction occurs in a RNA-dependent manner (By
CC       similarity). Interacts with dynein (By similarity). Interacts with FXR1
CC       and FXR2 (By similarity). Interacts with methylated histone H3 (By
CC       similarity). Interacts with IGF2BP1; this interaction allows to recruit
CC       IGF2BP1 to mRNA in a FMR1-dependent manner (By similarity). Interacts
CC       (via N-terminus) with KCNMB4 (By similarity). Interacts with KCNT1 (via
CC       C-terminus); this interaction alters gating properties of KCNT1
CC       (PubMed:20512134). Interacts (via C-terminus) with KIF5A; this
CC       interaction is increased in a mGluR-dependent manner (By similarity).
CC       Interacts (via phosphorylated form) with MCRS1 (via N-terminus) (By
CC       similarity). Interacts with MOV10; this interaction is direct, occurs
CC       in an RNA-dependent manner on polysomes and induces association of
CC       MOV10 with RNAs (By similarity). Interacts with MYO5A and PURA; these
CC       interactions occur in association with polyribosome (By similarity).
CC       Interacts with NCL (By similarity). Interacts with NUFIP1 (By
CC       similarity). Interacts (via N-terminus) with NUFIP2 (By similarity).
CC       Interacts with NXF1; this interaction occurs in a mRNA-dependent and
CC       polyribosome-independent manner in the nucleus (By similarity).
CC       Interacts with NXF2 (via N-terminus); this interaction is direct and
CC       occurs in a NXF1 mRNA-containing mRNP complexes (By similarity).
CC       Interacts with RANBP9; this interaction is direct and inhibits binding
CC       of FMR1 to RNA homomer (By similarity). Interacts with RPLP0 (By
CC       similarity). Interacts (via C-terminus) with SMN (via C-terminus); this
CC       interaction is direct and occurs in a RNA-independent manner (By
CC       similarity). Interacts with TDRD3 (via C-terminus); this interaction is
CC       direct (By similarity). Interacts with YBX1; this interaction occurs in
CC       association with polyribosome (By similarity). Interacts with
CC       nucleosome (By similarity). Associates with polyribosome; this
CC       association occurs in a mRNA-dependent manner (PubMed:14613971,
CC       PubMed:16571602, PubMed:9030614, PubMed:9144248). Associates with
CC       messenger ribonucleoprotein particles (mRNPs) (PubMed:16571602).
CC       Associates with microtubules in a kinesin- and dynein-dependent manner
CC       (By similarity). Interacts with HABP4 (By similarity). Interacts with
CC       SND1 (By similarity). {ECO:0000250|UniProtKB:P35922,
CC       ECO:0000250|UniProtKB:Q06787, ECO:0000269|PubMed:14613971,
CC       ECO:0000269|PubMed:16571602, ECO:0000269|PubMed:20512134,
CC       ECO:0000269|PubMed:24709664, ECO:0000269|PubMed:9030614,
CC       ECO:0000269|PubMed:9144248}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9030614}. Nucleus,
CC       nucleolus {ECO:0000250|UniProtKB:Q06787}. Chromosome, centromere
CC       {ECO:0000250|UniProtKB:P35922}. Chromosome
CC       {ECO:0000250|UniProtKB:P35922}. Cytoplasm, perinuclear region
CC       {ECO:0000250|UniProtKB:P35922}. Perikaryon
CC       {ECO:0000269|PubMed:14613971, ECO:0000269|PubMed:15028757,
CC       ECO:0000269|PubMed:15564573, ECO:0000269|PubMed:16571602,
CC       ECO:0000269|PubMed:24709664, ECO:0000269|PubMed:9030614,
CC       ECO:0000269|PubMed:9144248}. Cytoplasm, Cytoplasmic ribonucleoprotein
CC       granule {ECO:0000269|PubMed:15028757, ECO:0000269|PubMed:16098134,
CC       ECO:0000269|PubMed:23891804}. Cytoplasm, Stress granule
CC       {ECO:0000250|UniProtKB:Q06787}. Cell projection, neuron projection
CC       {ECO:0000269|PubMed:14613971, ECO:0000269|PubMed:24709664}. Cell
CC       projection, dendrite {ECO:0000269|PubMed:15028757,
CC       ECO:0000269|PubMed:15564573, ECO:0000269|PubMed:16571602,
CC       ECO:0000269|PubMed:9030614, ECO:0000269|PubMed:9144248}. Cell
CC       projection, dendritic spine {ECO:0000269|PubMed:15028757,
CC       ECO:0000269|PubMed:16098134, ECO:0000269|PubMed:9030614,
CC       ECO:0000269|PubMed:9144248}. Cell projection, growth cone
CC       {ECO:0000269|PubMed:16098134}. Cell projection, filopodium
CC       {ECO:0000269|PubMed:16098134}. Cell projection, filopodium tip
CC       {ECO:0000250|UniProtKB:P35922}. Cell projection, axon
CC       {ECO:0000269|PubMed:9030614}. Synapse {ECO:0000269|PubMed:15028757}.
CC       Synapse, synaptosome {ECO:0000269|PubMed:15564573,
CC       ECO:0000269|PubMed:24709664, ECO:0000269|PubMed:9030614,
CC       ECO:0000269|PubMed:9144248}. Postsynaptic density
CC       {ECO:0000269|PubMed:9144248}. Presynaptic cell membrane
CC       {ECO:0000250|UniProtKB:P35922}. Cell membrane
CC       {ECO:0000250|UniProtKB:P35922}. Note=Colocalizes with H2AX/H2A.x in
CC       pericentromeric heterochromatin in response to DNA damaging agents (By
CC       similarity). Localizes on meiotic pachytene-stage chromosomes (By
CC       similarity). Forms nuclear foci representing sites of ongoing DNA
CC       replication in response to DNA damaging agents (By similarity).
CC       Shuttles between nucleus and cytoplasm in a XPO1/CRM1-dependent manner
CC       (By similarity). Localizes to cytoplasmic granules, also referred to as
CC       messenger ribonucleoprotein particles or mRNPs, along dendrites and
CC       dendritic spines (PubMed:15028757, PubMed:23891804). FMR1-containing
CC       cytoplasmic granules colocalize to F-actin-rich structures, including
CC       filopodium, spines and growth cone during the development of
CC       hippocampal neurons (PubMed:16098134). FMR1-containing cytoplasmic
CC       granules are transported out of the soma along axon and dendrite to
CC       synaptic contacts in a microtubule- and kinesin-dependent manner
CC       (PubMed:16098134). Colocalizes with CACNA1B in the cytoplasm and at the
CC       cell membrane of neurons (By similarity). Colocalizes with CYFIP1,
CC       CYFIP2, NXF2 and ribosomes in the perinuclear region (By similarity).
CC       Colocalizes with CYFIP1 and EIF4E in dendrites and probably at synapses
CC       (By similarity). Colocalizes with FXR1, kinesin, 60S acidic ribosomal
CC       protein RPLP0 and SMN in cytoplasmic granules in the soma and neurite
CC       cell processes (By similarity). Colocalizes with FXR1 and FXR2 in
CC       discrete granules, called fragile X granules (FXGs), along axon and
CC       presynaptic compartments (By similarity). Colocalizes with TDRD3 in
CC       cytoplasmic stress granules (SGs) in response to various cellular
CC       stress (By similarity). {ECO:0000250|UniProtKB:P35922,
CC       ECO:0000250|UniProtKB:Q06787, ECO:0000269|PubMed:15028757,
CC       ECO:0000269|PubMed:16098134, ECO:0000269|PubMed:23891804}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q80WE1-1; Sequence=Displayed;
CC       Name=2; Synonyms=18;
CC         IsoId=Q80WE1-2; Sequence=VSP_034393;
CC   -!- TISSUE SPECIFICITY: Expressed in brain (PubMed:9030614). Expressed in
CC       neurons (PubMed:9030614). Expressed in mature oligodendrocytes (OLGs)
CC       (PubMed:23891804). Expressed in oligodendroglia progenitor cells (OPCs)
CC       and immature oligodendrocytes (OLGs) in the neonatal brain (at protein
CC       level) (PubMed:14613971). {ECO:0000269|PubMed:14613971,
CC       ECO:0000269|PubMed:23891804, ECO:0000269|PubMed:9030614}.
CC   -!- INDUCTION: Up-regulated in response to the activation of group I
CC       metabotropic glutamate receptors at synapses (PubMed:9144248). Rapidly
CC       and transiently up-regulated in response to light exposure in the cell
CC       bodies and dendrites of visual cortical neurons (at protein level)
CC       (PubMed:15564573). {ECO:0000269|PubMed:15564573,
CC       ECO:0000269|PubMed:9144248}.
CC   -!- DOMAIN: The N-terminal 134 amino acids are necessary for
CC       homodimerization and RNA-binding. The N-terminal 298 amino acids are
CC       sufficient to interact with KCNMB4 and to regulate presynaptic action
CC       potential (AP) duration in neurons. The two agenet-like domains are
CC       necessary for binding to histone H3 in a methylation-dependent manner.
CC       The KH domains are necessary for mediating miRNA annealing to specific
CC       RNA targets. The KH 2 domain is necessary for binding to kissing
CC       complex (kc) RNA ligands. The RGG box domain is necessary for binding
CC       to mRNA targets that contain G-quadruplex structures. The RGG-box
CC       domain is necessary for binding to a triple stem-loop RNA structure,
CC       called Sod1 stem loop interacting with FMRP (SoSLIP), in the superoxide
CC       dismutase SOD1 mRNA. The RGG box domain is necessary for binding to its
CC       own mRNA. The RGG-box domain is necessary for binding to homomer
CC       poly(G). {ECO:0000250|UniProtKB:Q06787}.
CC   -!- DOMAIN: The C-terminal disordered region undergoes liquid-liquid phase
CC       separation (LLPS) for the formation of a membraneless compartment that
CC       concentrates mRNAs with associated regulatory factors.
CC       {ECO:0000250|UniProtKB:Q06787}.
CC   -!- PTM: Phosphorylated on several serine residues. Phosphorylation at Ser-
CC       478 is required for phosphorylation of other nearby serine residues.
CC       Phosphorylation has no effect on the binding of individual mRNA
CC       species. Unphosphorylated FMR1 is associated with actively translating
CC       polyribosome, whereas a fraction of phosphorylated FMR1 is associated
CC       with apparently stalled polyribosome. Dephosphorylation by an activated
CC       phosphatase may release the FMR1-mediated translational repression and
CC       allow synthesis of a locally required protein at synapses.
CC       {ECO:0000250|UniProtKB:P35922}.
CC   -!- PTM: Monoubiquitinated. Polyubiquitinated. Ubiquitinated and targeted
CC       for proteasomal degradation after activation of metabotropic glutamate
CC       receptor (mGluR). {ECO:0000250|UniProtKB:P35922}.
CC   -!- PTM: Monomethylated and asymmetrically dimethylated at four arginine
CC       residues of the arginine-glycine-glycine box. Methylation disrupts the
CC       binding of FMRP to RNAs through its RGG box. Methylation is necessary
CC       for heterodimerization with FXR1, association with polyribosomes,
CC       recruitment into stress granules and translation of FMR1 target mRNAs.
CC       Methylated by PRMT1, PRMT3 and PRMT4, in vitro.
CC       {ECO:0000250|UniProtKB:P35922, ECO:0000250|UniProtKB:Q06787}.
CC   -!- SIMILARITY: Belongs to the FMR1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB07073.1; Type=Miscellaneous discrepancy; Note=N-ter sequencing errors.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY240947; AAP15341.1; -; mRNA.
DR   EMBL; U60145; AAB07073.1; ALT_SEQ; mRNA.
DR   RefSeq; NP_434691.1; NM_052804.1. [Q80WE1-2]
DR   RefSeq; XP_006229594.1; XM_006229532.3. [Q80WE1-1]
DR   AlphaFoldDB; Q80WE1; -.
DR   SMR; Q80WE1; -.
DR   BioGRID; 247050; 4.
DR   IntAct; Q80WE1; 2.
DR   MINT; Q80WE1; -.
DR   STRING; 10116.ENSRNOP00000071204; -.
DR   GlyGen; Q80WE1; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q80WE1; -.
DR   PhosphoSitePlus; Q80WE1; -.
DR   jPOST; Q80WE1; -.
DR   PaxDb; 10116-ENSRNOP00000016227; -.
DR   Ensembl; ENSRNOT00000087893.2; ENSRNOP00000074033.1; ENSRNOG00000057464.2. [Q80WE1-2]
DR   Ensembl; ENSRNOT00055041306; ENSRNOP00055033609; ENSRNOG00055023990. [Q80WE1-1]
DR   Ensembl; ENSRNOT00060032915; ENSRNOP00060026912; ENSRNOG00060018894. [Q80WE1-1]
DR   Ensembl; ENSRNOT00065036800; ENSRNOP00065029638; ENSRNOG00065021607. [Q80WE1-1]
DR   GeneID; 24948; -.
DR   KEGG; rno:24948; -.
DR   AGR; RGD:2623; -.
DR   CTD; 2332; -.
DR   RGD; 2623; Fmr1.
DR   VEuPathDB; HostDB:ENSRNOG00000057464; -.
DR   eggNOG; ENOG502QPKJ; Eukaryota.
DR   GeneTree; ENSGT00950000183189; -.
DR   InParanoid; Q80WE1; -.
DR   OrthoDB; 2995592at2759; -.
DR   PhylomeDB; Q80WE1; -.
DR   PRO; PR:Q80WE1; -.
DR   Proteomes; UP000002494; Chromosome X.
DR   Bgee; ENSRNOG00000057464; Expressed in thymus and 20 other cell types or tissues.
DR   ExpressionAtlas; Q80WE1; baseline and differential.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:1904115; C:axon cytoplasm; IEA:GOC.
DR   GO; GO:0043679; C:axon terminus; IDA:UniProtKB.
DR   GO; GO:0015030; C:Cajal body; ISO:RGD.
DR   GO; GO:0044297; C:cell body; IDA:MGI.
DR   GO; GO:0042995; C:cell projection; ISO:RGD.
DR   GO; GO:0010369; C:chromocenter; ISS:UniProtKB.
DR   GO; GO:0005694; C:chromosome; ISS:UniProtKB.
DR   GO; GO:0000775; C:chromosome, centromeric region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IDA:UniProtKB.
DR   GO; GO:0010494; C:cytoplasmic stress granule; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:1902737; C:dendritic filopodium; IDA:UniProtKB.
DR   GO; GO:0043197; C:dendritic spine; IDA:UniProtKB.
DR   GO; GO:0044327; C:dendritic spine head; IDA:RGD.
DR   GO; GO:0044326; C:dendritic spine neck; IDA:RGD.
DR   GO; GO:0032433; C:filopodium tip; ISS:UniProtKB.
DR   GO; GO:0097386; C:glial cell projection; IDA:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0030426; C:growth cone; IDA:UniProtKB.
DR   GO; GO:1990812; C:growth cone filopodium; ISS:UniProtKB.
DR   GO; GO:0098686; C:hippocampal mossy fiber to CA3 synapse; ISO:RGD.
DR   GO; GO:0043232; C:intracellular non-membrane-bounded organelle; ISO:RGD.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:MGI.
DR   GO; GO:0043005; C:neuron projection; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0071598; C:neuronal ribonucleoprotein granule; IDA:MGI.
DR   GO; GO:0005730; C:nucleolus; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0098794; C:postsynapse; ISO:RGD.
DR   GO; GO:0099524; C:postsynaptic cytosol; IDA:SynGO.
DR   GO; GO:0014069; C:postsynaptic density; IDA:UniProtKB.
DR   GO; GO:0098793; C:presynapse; ISS:UniProtKB.
DR   GO; GO:0099523; C:presynaptic cytosol; ISO:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:1990635; C:proximal dendrite; IDA:RGD.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISO:RGD.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IDA:SynGO.
DR   GO; GO:0032797; C:SMN complex; ISO:RGD.
DR   GO; GO:0097444; C:spine apparatus; IDA:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0070840; F:dynein complex binding; ISS:UniProtKB.
DR   GO; GO:0002151; F:G-quadruplex RNA binding; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0035064; F:methylated histone binding; ISS:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; ISS:UniProtKB.
DR   GO; GO:0035198; F:miRNA binding; ISS:UniProtKB.
DR   GO; GO:0140693; F:molecular condensate scaffold activity; ISS:UniProtKB.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; ISS:UniProtKB.
DR   GO; GO:0048027; F:mRNA 5'-UTR binding; ISS:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IPI:RGD.
DR   GO; GO:1990247; F:N6-methyladenosine-containing RNA reader activity; ISS:UniProtKB.
DR   GO; GO:0008143; F:poly(A) binding; ISO:RGD.
DR   GO; GO:0034046; F:poly(G) binding; ISS:UniProtKB.
DR   GO; GO:0008266; F:poly(U) RNA binding; ISS:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IDA:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0019903; F:protein phosphatase binding; IDA:RGD.
DR   GO; GO:0043022; F:ribosome binding; ISO:RGD.
DR   GO; GO:0000340; F:RNA 7-methylguanosine cap binding; IDA:RGD.
DR   GO; GO:0003723; F:RNA binding; IDA:RGD.
DR   GO; GO:0035613; F:RNA stem-loop binding; ISS:UniProtKB.
DR   GO; GO:0033592; F:RNA strand annealing activity; ISS:UniProtKB.
DR   GO; GO:1990825; F:sequence-specific mRNA binding; ISS:UniProtKB.
DR   GO; GO:0035591; F:signaling adaptor activity; ISO:RGD.
DR   GO; GO:0035197; F:siRNA binding; ISS:UniProtKB.
DR   GO; GO:0031369; F:translation initiation factor binding; ISO:RGD.
DR   GO; GO:0045182; F:translation regulator activity; IBA:GO_Central.
DR   GO; GO:0030371; F:translation repressor activity; ISS:UniProtKB.
DR   GO; GO:0044325; F:transmembrane transporter binding; ISO:RGD.
DR   GO; GO:0048513; P:animal organ development; IBA:GO_Central.
DR   GO; GO:0008089; P:anterograde axonal transport; ISO:RGD.
DR   GO; GO:1905232; P:cellular response to L-glutamate; IEP:RGD.
DR   GO; GO:0035865; P:cellular response to potassium ion; IEP:RGD.
DR   GO; GO:0098586; P:cellular response to virus; ISO:RGD.
DR   GO; GO:0007417; P:central nervous system development; ISO:RGD.
DR   GO; GO:0060996; P:dendritic spine development; ISO:RGD.
DR   GO; GO:0050974; P:detection of mechanical stimulus involved in sensory perception; IEP:RGD.
DR   GO; GO:0006281; P:DNA repair; ISS:UniProtKB.
DR   GO; GO:0098817; P:evoked excitatory postsynaptic potential; IMP:RGD.
DR   GO; GO:0098976; P:excitatory chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0007215; P:glutamate receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0098977; P:inhibitory chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0090461; P:intracellular glutamate homeostasis; IMP:RGD.
DR   GO; GO:0035641; P:locomotory exploration behavior; IMP:RGD.
DR   GO; GO:0035195; P:miRNA-mediated post-transcriptional gene silencing; ISS:UniProtKB.
DR   GO; GO:0044830; P:modulation by host of viral RNA genome replication; ISO:RGD.
DR   GO; GO:0006406; P:mRNA export from nucleus; ISS:UniProtKB.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0051028; P:mRNA transport; ISS:UniProtKB.
DR   GO; GO:2000766; P:negative regulation of cytoplasmic translation; ISS:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:RGD.
DR   GO; GO:1900453; P:negative regulation of long-term synaptic depression; ISS:UniProtKB.
DR   GO; GO:0060965; P:negative regulation of miRNA-mediated gene silencing; ISS:UniProtKB.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IMP:RGD.
DR   GO; GO:0010955; P:negative regulation of protein processing; IMP:RGD.
DR   GO; GO:0002091; P:negative regulation of receptor internalization; IMP:RGD.
DR   GO; GO:2000301; P:negative regulation of synaptic vesicle exocytosis; IMP:UniProtKB.
DR   GO; GO:0017148; P:negative regulation of translation; ISS:UniProtKB.
DR   GO; GO:0045947; P:negative regulation of translational initiation; ISS:UniProtKB.
DR   GO; GO:1901386; P:negative regulation of voltage-gated calcium channel activity; IMP:UniProtKB.
DR   GO; GO:0140694; P:non-membrane-bounded organelle assembly; ISS:UniProtKB.
DR   GO; GO:0001541; P:ovarian follicle development; IEP:RGD.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; ISS:UniProtKB.
DR   GO; GO:0051491; P:positive regulation of filopodium assembly; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:RGD.
DR   GO; GO:1901254; P:positive regulation of intracellular transport of viral material; ISO:RGD.
DR   GO; GO:0048170; P:positive regulation of long-term neuronal synaptic plasticity; IMP:RGD.
DR   GO; GO:1900454; P:positive regulation of long-term synaptic depression; IMP:RGD.
DR   GO; GO:1900273; P:positive regulation of long-term synaptic potentiation; IMP:RGD.
DR   GO; GO:2000637; P:positive regulation of miRNA-mediated gene silencing; ISS:UniProtKB.
DR   GO; GO:1901800; P:positive regulation of proteasomal protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:RGD.
DR   GO; GO:0002092; P:positive regulation of receptor internalization; ISS:UniProtKB.
DR   GO; GO:0050806; P:positive regulation of synaptic transmission; IMP:RGD.
DR   GO; GO:0045727; P:positive regulation of translation; ISS:UniProtKB.
DR   GO; GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; ISS:UniProtKB.
DR   GO; GO:0060998; P:regulation of dendritic spine development; ISS:UniProtKB.
DR   GO; GO:0051489; P:regulation of filopodium assembly; ISS:UniProtKB.
DR   GO; GO:1905244; P:regulation of modification of synaptic structure; ISO:RGD.
DR   GO; GO:0043488; P:regulation of mRNA stability; ISS:UniProtKB.
DR   GO; GO:0098908; P:regulation of neuronal action potential; IMP:RGD.
DR   GO; GO:0046928; P:regulation of neurotransmitter secretion; IMP:UniProtKB.
DR   GO; GO:0006417; P:regulation of translation; TAS:RGD.
DR   GO; GO:0099578; P:regulation of translation at postsynapse, modulating synaptic transmission; ISO:RGD.
DR   GO; GO:0099577; P:regulation of translation at presynapse, modulating synaptic transmission; IDA:SynGO.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:0042220; P:response to cocaine; IEP:RGD.
DR   GO; GO:0051602; P:response to electrical stimulus; IEP:RGD.
DR   GO; GO:0034698; P:response to gonadotropin; IEP:RGD.
DR   GO; GO:0070555; P:response to interleukin-1; IEP:RGD.
DR   GO; GO:0097396; P:response to interleukin-17; ISO:RGD.
DR   GO; GO:0009416; P:response to light stimulus; IEP:RGD.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   GO; GO:0060538; P:skeletal muscle organ development; ISS:UniProtKB.
DR   GO; GO:0035176; P:social behavior; ISO:RGD.
DR   GO; GO:0034063; P:stress granule assembly; ISS:UniProtKB.
DR   GO; GO:0019226; P:transmission of nerve impulse; ISO:RGD.
DR   CDD; cd22506; KH_I_FMR1_rpt1; 1.
DR   CDD; cd22509; KH_I_FMR1_rpt2; 1.
DR   CDD; cd22512; KH_I_FMR1_rpt3; 1.
DR   CDD; cd20471; Tudor_Agenet_FMR1_rpt1; 1.
DR   CDD; cd20474; Tudor_Agenet_FMR1_rpt2; 1.
DR   Gene3D; 2.30.30.140; -; 2.
DR   Gene3D; 3.30.1370.10; K Homology domain, type 1; 2.
DR   InterPro; IPR008395; Agenet-like_dom.
DR   InterPro; IPR040148; FMR1.
DR   InterPro; IPR022034; FMR1-like_C_core.
DR   InterPro; IPR032196; FMR1_C2.
DR   InterPro; IPR040472; FMRP_KH0.
DR   InterPro; IPR004087; KH_dom.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR036612; KH_dom_type_1_sf.
DR   InterPro; IPR047438; KH_I_FMR1_rpt1.
DR   InterPro; IPR047440; KH_I_FMR1_rpt2.
DR   InterPro; IPR047431; Tudor_Agenet_FMR1_rpt1.
DR   InterPro; IPR047436; Tudor_Agenet_FMR1_rpt2.
DR   InterPro; IPR041560; Tudor_FRM1.
DR   PANTHER; PTHR10603; FRAGILE X MENTAL RETARDATION SYNDROME-RELATED PROTEIN; 1.
DR   PANTHER; PTHR10603:SF4; SYNAPTIC FUNCTIONAL REGULATOR FMR1; 1.
DR   Pfam; PF05641; Agenet; 1.
DR   Pfam; PF16098; FXMR_C2; 1.
DR   Pfam; PF12235; FXMRP1_C_core; 1.
DR   Pfam; PF00013; KH_1; 2.
DR   Pfam; PF17904; KH_9; 1.
DR   Pfam; PF18336; Tudor_FRX1; 1.
DR   SMART; SM00322; KH; 2.
DR   SUPFAM; SSF54791; Eukaryotic type KH-domain (KH-domain type I); 2.
DR   PROSITE; PS51641; AGENET_LIKE; 2.
DR   PROSITE; PS50084; KH_TYPE_1; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Alternative splicing; Cell membrane;
KW   Cell projection; Centromere; Chromosome; Cytoplasm; DNA damage; Membrane;
KW   Methylation; mRNA processing; mRNA splicing; mRNA transport; Neurogenesis;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat; Repressor;
KW   Ribonucleoprotein; RNA-binding; RNA-mediated gene silencing; Synapse;
KW   Synaptosome; Translation regulation; Transport; Ubl conjugation.
FT   CHAIN           1..593
FT                   /note="Fragile X messenger ribonucleoprotein 1"
FT                   /id="PRO_0000342185"
FT   DOMAIN          4..50
FT                   /note="Agenet-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00973"
FT   DOMAIN          63..115
FT                   /note="Agenet-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00973"
FT   DOMAIN          218..279
FT                   /note="KH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          281..348
FT                   /note="KH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   REGION          1..184
FT                   /note="Required for nuclear localization"
FT                   /evidence="ECO:0000250|UniProtKB:P35922"
FT   REGION          172..211
FT                   /note="Necessary for interaction with CYFIP1, CYFIP2, FXR1
FT                   and FXR2"
FT                   /evidence="ECO:0000250|UniProtKB:P35922,
FT                   ECO:0000250|UniProtKB:Q06787"
FT   REGION          323..370
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          375..469
FT                   /note="Required for nuclear export"
FT                   /evidence="ECO:0000250|UniProtKB:Q06787"
FT   REGION          397..593
FT                   /note="Interaction with RANBP9"
FT                   /evidence="ECO:0000250|UniProtKB:Q06787"
FT   REGION          421..593
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          512..526
FT                   /note="RNA-binding RGG-box"
FT                   /evidence="ECO:0000250"
FT   MOTIF           402..421
FT                   /note="Nuclear export signal"
FT                   /evidence="ECO:0000250|UniProtKB:P35922"
FT   MOTIF           505..512
FT                   /note="Nucleolar localization signal 1"
FT                   /evidence="ECO:0000250|UniProtKB:Q06787"
FT   MOTIF           574..578
FT                   /note="Nucleolar localization signal 2"
FT                   /evidence="ECO:0000250|UniProtKB:Q06787"
FT   COMPBIAS        329..347
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        478..515
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        527..549
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        550..564
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        565..582
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06787"
FT   MOD_RES         336
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         337
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         347
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         349
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         350
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         369
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06787"
FT   MOD_RES         441
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P35922"
FT   MOD_RES         449
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P35922"
FT   MOD_RES         478
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06787"
FT   MOD_RES         480
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06787"
FT   MOD_RES         482
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06787"
FT   MOD_RES         489
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06787"
FT   MOD_RES         492
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06787"
FT   MOD_RES         496
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06787"
FT   MOD_RES         512
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P35922"
FT   MOD_RES         512
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P35922"
FT   MOD_RES         517
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P35922"
FT   MOD_RES         517
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P35922"
FT   MOD_RES         522
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P35922"
FT   MOD_RES         522
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P35922"
FT   MOD_RES         524
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P35922"
FT   MOD_RES         524
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P35922"
FT   MOD_RES         551
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06787"
FT   MOD_RES         552
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06787"
FT   MOD_RES         559
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06787"
FT   MOD_RES         581
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35922"
FT   VAR_SEQ         469..480
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_034393"
FT   CONFLICT        110
FT                   /note="E -> D (in Ref. 2; AAB07073)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        184
FT                   /note="L -> S (in Ref. 2; AAB07073)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        424
FT                   /note="A -> V (in Ref. 2; AAB07073)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   593 AA;  66780 MW;  8EFBEC47E6B818F4 CRC64;
     MEELVVEVRG SNGAFYKAFV KDVHEDSITV AFENNWQPER QIPFHDVRFP PPVGYNKDIN
     ESDEVEVYSR ANEKEPCCWW LAKVRMIKGE FYVIEYAACD ATYNEIVTIE RLRSVNPNKP
     ATKDTFHKIK LEVPEDLRQM CAKESAHKDF KKAVGAFSVT YDPENYQLVI LSINEVTSKR
     AHMLIDMHFR SLRTKLSLIL RNEEASKQLE SSRQLASRFH EQFIVREDLM GLAIGTHGAN
     IQQARKVPGV TAIDLDEDTC TFHIYGEDQD AVKKARSFLE FAEDVIQVPR NLVGKVIGKN
     GKLIQEIVDK SGVVRVRIEA ENEKSVPQEE ENLPPSSLPS NNSRVGSNSS EEKKHLDTKE
     NTHFSQPNST KVQRGMVPFV FVGTKDSIAN ATVLLDYHLN YLKEVDQLRL ERLQIDEQLR
     QIGASSRPPP NRTDKEKGYV TDDGQGMGRG SRPYRNRGHG RRGPGYTSGT NSEASNASET
     ESDHRDELSD WSLAPTEEER ESFLRRGDGR RRGGGGRGQG GRGRGGGFKG NDDHSRTDNR
     PRNPRETKGR TTDGSLQSTS SEGSRLRTGK DRNQKKEKPD SVDGLQPLVN GVP
//
